3 results
Approved WMOWill not start
Using a single formulation of PfPEBS LSP administered at two different doses, one of 5*g and the other one of 30*g, both adjuvanted with aluminium hydroxide, in two immunizations at 28 days interval, to evaluate a) the safety and immunogenicity (…
Approved WMORecruiting
1 Primary objectiveTo demonstrate that the minimally invasive surgical procedure in combination with the use of the BA400 abutment is associated with a reduction of inflammation/ infection, overgrowth, pain and numbness at the site of implantation…
Approved WMOCompleted
This study is aimed to determine the efficacy of varenicline in reducing EDS in PD patients.